⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ANIP News
ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals to Discuss Third Quarter 2026 Financial Results on November 5, 2026 at 8:00 a.m. ET
globenewswire.com
ANIP
ANI Pharmaceuticals Announces the Launch of Duloxetine Delayed-Release Capsules
globenewswire.com
ANIP
ANI Pharmaceuticals Announces Positive Phase 4 Open-Label, Single-Arm SYNCHRONICITY Clinical Trial Results Presented as Late Breaking Oral Presentation at the American Academy of Ophthalmology 2026 Annual Meeting
globenewswire.com
ANIP
ANI Pharmaceuticals Announces New Fluocinolone Acetonide Intravitreal Implant Data to be Presented at the American Academy of Ophthalmology 2026 Annual Meeting
globenewswire.com
ANIP
ANI Pharmaceuticals Announces the FDA Approval of Everolimus Tablets for Oral Suspension
globenewswire.com
ANIP
ANI Pharmaceuticals to Present at September Investor Conferences
globenewswire.com
ANIP
Form 8-K
sec.gov
ANIP
ANI Pharmaceuticals Appoints Henry Gosebruch to Board of Directors
globenewswire.com
ANIP
Form 8-K
sec.gov
ANIP
ANI Pharmaceuticals Reports Record Second Quarter 2026 Financial Results
globenewswire.com
ANIP